SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,515.43 362.57
( 0.48%)

Global Indices

Nasdaq

53,423.66 -283.45
(-0.53%)

Dow Jones

7,737.34 -31.37
(-0.40%)

Hang Seng

65,002.68 788.20
(1.23%)

Nikkei 225

10,828.70 -2.82
(-0.03%)

Forex

USD-INR

94.48 -0.24
(-0.26%)

EUR-INR

109.71 0.00
(0.00%)

GBP-INR

127.63 -0.19
(-0.15%)

JPY-INR

0.60 0.01
(1.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

18.6032787

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

43.06

82.73

EPS(TTM)

Face Value()

Div & Yield %

1.26

Back

Dr Lal Pathlabs consolidated net profit rises 28.02% in the June 2026 quarter

Jul 24,2026

Net profit of Dr Lal Pathlabs rose 28.02% to Rs 169.50 crore in the quarter ended June 2026 as against Rs 132.40 crore during the previous quarter ended June 2025. Sales rose 19.10% to Rs 797.70 crore in the quarter ended June 2026 as against Rs 669.80 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	797.70	669.80	19
OPM %	31.03	28.71	-
PBDT	273.10	215.70	27
PBT	228.70	181.10	26
NP	169.50	132.40	28

76,515.43 362.57 ( 0.48%)

53,423.66 -283.45 (-0.53%)

7,737.34 -31.37 (-0.40%)

65,002.68 788.20 (1.23%)

10,828.70 -2.82 (-0.03%)

94.48 -0.24 (-0.26%)

109.71 0.00 (0.00%)

127.63 -0.19 (-0.15%)

0.60 0.01 (1.60%)